This is the original version (as it was originally made).
4.—(1) An application made to a Primary Care Trust under Part 5 of the 2005 Regulations (provision of pharmaceutical services by doctors) for outline consent or premises approval (including temporary premises approval) which—
(a)has not been determined before the appointed day; and
(b)by virtue of Schedule 7 to the 2012 Regulations (transitional provisions) was to be determined in accordance with the 2005 Regulations,
is to be dealt with by the NHSCB in accordance with the 2005 Regulations.
(2) Where an application under Part 5 of the 2005 Regulations has been determined in accordance with those Regulations, whether before the appointed day or by virtue of sub-paragraph (1)—
(a)the arrangements for bringing an appeal in relation to that application; and
(b)the determination of any appeal validly brought,
are to be in accordance with the 2005 Regulations.
(3) If, before the appointed day—
(a)a Primary Care Trust has required a doctor to provide pharmaceutical services under regulation 60(4)(a) of the 2005 Regulations(1) (arrangements for provision of pharmaceutical services by doctors); and
(b)the doctor has appealed against that decision,
the arrangements for bringing that appeal, and the determination of any appeal validly brought, are to be in accordance with the 2005 Regulations.
Prior to its revocation, regulation 60(4) was amended by S.I. 2005/1015 and 2006/3373.
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
